Protocol for a feasibility and early efficacy study of the Comprehensive Lifestyle Improvement Program for Prostate Cancer-2 (CLIPP2)

Background: Although androgen deprivation therapy (ADT) for prostate cancer demonstrates improved overall and disease-free survival, it is associated with adverse effects such as obesity and metabolic syndrome that increase risk of cardiometabolic disease and diabetes type 2. ADT also leads to fatig...

Full description

Bibliographic Details
Main Authors: A.M. Algotar, R. Kumar, H.M. Babiker, S.T. Dougherty, C.H. Hsu, H.-H. Chow, T.E. Smith, D.G. Marrero, K.S. Courneya, I. Abraham, J.A. Ligibel, C.A. Thomson
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:Contemporary Clinical Trials Communications
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865421000041